Clinical Trial Supply and Logistics Market Report 2026

The clinical trial supply and logistics market size has grown strongly in recent years. It will grow from $5.1 billion in 2025 to $5.56 billion in 2026 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to increasing number of global clinical trials, expansion of multinational study designs, growing complexity of trial protocols, rising demand for temperature-controlled logistics, increased outsourcing of trial supply functions.

The clinical trial supply and logistics market size is expected to see strong growth in the next few years. It will grow to $7.92 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to increasing adoption of decentralized clinical trials, rising demand for patient-centric supply models, expansion of biologics and cell therapy trials, growing investments in digital trial logistics platforms, increasing focus on real-time supply monitoring. Major trends in the forecast period include increasing adoption of integrated cold chain logistics, rising demand for end-to-end trial supply visibility, growing use of centralized inventory management models, expansion of direct-to-patient supply models, enhanced focus on risk mitigation and supply continuity.

The increasing number of clinical trials is expected to drive the growth of the clinical trial supply and logistics market in the coming years. Clinical trials are research studies conducted with human participants to assess the safety and effectiveness of new medical treatments, interventions, or diagnostic procedures. Clinical trial supply and logistics support these studies by ensuring the timely provision of materials such as investigational drugs, clinical kits, and biological specimen collection and delivery, as well as offering expertise for regulatory approvals and customs clearance. These services help ensure smooth trial operations and the successful execution of research activities. For instance, in July 2023, according to ClinicalTrials.gov, a US-based registry operated by the National Library of Medicine at the National Institutes of Health, the number of registered clinical studies increased from 399,499 in 2022 to 437,533 by July 2023 across all 50 U.S. states and 221 countries. Of these, 141,513 studies, representing 31% of the total, were registered in the United States, while 244,707 studies, or 53%, were registered outside the U.S. Therefore, the rising number of clinical trials is driving the growth of the clinical trial supply and logistics market.

Major companies operating in the clinical trial supply and logistics market are focusing on innovations such as temperature-controlled healthcare shipments to maintain product integrity during transportation, ensure regulatory compliance, and improve patient outcomes. Temperature-controlled healthcare shipments involve transporting pharmaceuticals, biologics, and medical materials under strictly regulated temperature conditions to preserve their safety and effectiveness. This process relies on specialized packaging, continuous monitoring systems, and advanced logistics solutions to maintain required temperature ranges throughout transit. For instance, in February 2024, FedEx Corporation, a US-based transportation company, launched the FedEx Life Science Center through FedEx Customized Freight for the transport of critical pharmaceutical shipments. This service includes features such as priority boarding, end-to-end custodial control, and dedicated delivery options designed to protect product integrity. Customers can also use FedEx Priority Alert Plus, which provides proactive monitoring of time-sensitive shipments and options for replenishing dry ice or gel packs during transit.

In November 2025, UPS Healthcare, a US-based provider of logistics and supply chain solutions, acquired Andlauer Healthcare Group for an undisclosed amount. Through this acquisition, UPS Healthcare aims to expand its cold chain logistics capabilities, strengthen temperature-sensitive healthcare transportation services, enhance its service coverage across North America, and improve the efficiency and reliability of pharmaceutical and biotechnology supply chains. Andlauer Healthcare Group is a Canada-based cold chain logistics company specializing in refrigerated and temperature-controlled transportation and storage solutions for healthcare products.

Major companies operating in the clinical trial supply and logistics market are United Parcel Service, DHL Group, FedEx Corporation, Thermo Fisher Scientific Inc., IQVIA, ICON plc, Eurofins Scientific, Catalent Inc., Intertek Group plc, Parexel International Corporation, UDG Healthcare PLC., Almac Group, World Courier, Piramal Pharma Solutions, Sharp Clinical Services Ltd., Clinigen Group, PCI Pharma Services, Movianto Group, Cold Chain Technologies, Biocair International Limited, QuickSTAT, Wasdell Group, Klifo A/S, TrakCel, Packaging Coordinators Inc., Biotec Services International Limited, Proventa International, Inceptua Group.

North America was the largest region in the clinical trial supply and logistics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical trial supply and logistics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the clinical trial supply and logistics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the clinical trial supply and logistics market by increasing costs of imported packaging materials, temperature-controlled containers, tracking devices, and specialized logistics equipment used in global trial distribution. North America and Europe are most affected due to cross-border shipment of investigational products, while Asia-Pacific faces higher costs for imported cold chain technologies. These tariffs are increasing operational expenses and extending trial timelines. However, they are also encouraging regional depot development, localized packaging operations, and diversified sourcing strategies that enhance long-term supply chain resilience.

The clinical trial supply and logistics market research report is one of a series of new reports that provides clinical trial supply and logistics market statistics, including clinical trial supply and logistics industry global market size, regional shares, competitors with a clinical trial supply and logistics market share, detailed clinical trial supply and logistics market segments, market trends and opportunities, and any further data you may need to thrive in the clinical trial supply and logistics industry. This clinical trial supply and logistics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Clinical trial supply and logistics involves the systematic process of planning and managing the timely, secure, and cost-effective delivery of supplies, equipment, and investigational products required for the conduct of clinical studies. This process is essential to ensure the safe, efficient, and compliant execution of clinical trials while maintaining cost control and operational efficiency.

The main services provided in clinical trial supply and logistics include logistics and distribution, storage and retention, packaging, labeling and blinding, manufacturing, comparator sourcing, and other related services. Logistics focuses on developing strategic plans for the movement of clinical trial materials, while distribution involves the execution of these plans through carefully coordinated transportation and delivery activities. These services support all phases of clinical trials, including Phase I, Phase II, Phase III, and Phase IV, across therapeutic areas such as oncology, cardiovascular diseases, respiratory diseases, central nervous system and mental disorders, and others. They are utilized by end users including pharmaceutical companies, biologics manufacturers, and medical device companies.

The clinical trial supply and logistics market includes revenues earned by entities by providing services such as clinical supply planning, import and export compliance, inventory management, packaging services, and real-time track and trace and delivery. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.